1) intravenous infusion preparation
静脉制剂
2) intravenous sodium valproate
丙戊酸静脉制剂
1.
ObjectiveTo explore the effect and safety of intravenous sodium valproate in treatment of pediatric patients with status epilepticus (SE).
目的探讨丙戊酸静脉制剂治疗儿童癫痫持续状态的疗效和安全性。
3) venous oxygen agents
静脉给氧制剂
1.
This paper reviewed published papers and discribed the application mechanism of hypertonic saline,venous oxygen agents,and hypertonic-hyperoxia intravenous compound preparation.
本文分别对高渗盐水、静脉给氧制剂、高渗高氧复方制剂的应用机制的研究情况进行综述。
4) intravenous emulsion
静脉乳剂
1.
Preparation and determination of physicochemical properties of ginsenoside C-K intravenous emulsions;
人参皂苷C-K静脉乳剂的制备及理化性质考察
2.
Objective: To prepare and evaluate an intravenous emulsion of tanshinone ⅡA.
目的:研制丹参酮ⅡA静脉乳剂,并对其进行质量评价。
3.
In this article, we had studied on the formulation and preparation technique of ginsenoside C-K intravenous emulsion and evaluated its physico-chemical stabilities、pharmacodynamics and safety.
本文研究了人参皂苷C-K静脉乳剂的处方及制备工艺，并对其稳定性、药效学及安全性进行了评价。
5) Intravenous iron
静脉铁剂
1.
Concerns of intravenous iron therapy in patients with renal anemia
肾性贫血患者静脉铁剂使用中值得关注的问题
2.
Purpose To observe the effects of ascorbic acid on the oxidative stress induced by intravenous iron in chronic hemodialysis patients.
目的 观察抗坏血酸透析液对静脉铁剂诱导的维持性血液透析患者氧化应激的影响。
3.
Background: The effect of intravenous iron on renal anemia has been recognized generally, and the oxidative stress caused by intravenous iron has been aware of gradually.
背景:静脉铁剂治疗肾性贫血的效果已经得到广泛的承认,但应用静脉铁剂可能引起氧化应激反应的现实也逐渐受到关注,特别是在已经证实较大剂量静脉铁剂治疗可产生氧化应激反应的情况下,长期应用小剂量静脉铁剂治疗肾性贫血成为必然。
6) intravenous injection
静脉注射剂
1.
Study for the source,aarmfulness and preventive measures of particulate matter in intravenous injection;
静脉注射剂中不溶性微粒的来源、危害及预防措施
2.
The development of cremophor EL free intravenous injection of paclitaxel is reviewed, including complexes with 2 hydroxypropyl β cyclodextrin, intravenous emulsions, submicroemulsions and microemulsions, and suspensions of nanocrystalline, nanoparticles.
综述了近年来不含聚氧乙烯蓖麻油的紫杉醇静脉注射剂的研究进展 ,包括 2 -羟丙基倍他环糊精包合物、静脉注射用普通乳、亚微乳、微乳、毫微晶混悬液以及毫微粒等。
补充资料：经皮经颈静脉肝内门体静脉内支架分流术
经皮经颈静脉肝内门体静脉内支架分流术
介入放射学技术。也称经皮经颈静脉肝内门体静脉分流术(TIPS)，1969年最初由Rosch等首先报道。经颈静脉送入导丝，于门-腔静脉间经肝实质建立通道，并放入支架以形成永久性分流径路的治疗方式，以降低门脉压力，治疗顽固性的食管胃底静脉曲张出血及顽固性的腹水。该技术除常规导丝、导管、球囊扩张导管等外，需向建立的分流通道内置入支架，常用的有Z-型支架、Wallstent支架、Strecker支架等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条